Usona Statement on Phase 3 Study of Psilocybin for Major Depressive Disorder (MDD) (uAspire)
March 20, 2024
Usona Institute Research Unveils New Compounds with Observed Psychedelic-like Activity
January 10, 2024
Usona Identifies Controlled Crystal Engineering Process for Large-Scale Synthesis of Psilocybin Polymorphs
February 7, 2022
Crystallographic Discoveries Bring New Clarity to Pharmaceutical Psilocybin Polymorph Characterization
December 20, 2021
Usona Institute Breaks Ground for Global Center in Psychedelic Science
August 3, 2021
Usona Institute Publishes Synthesis and Characterization of cGMP 5-MeO-DMT
December 8, 2020
Usona Institute Publishes Breakthrough Development in Scalable Psilocybin Synthesis
August 3, 2020
